{
  "disease_name": "Dengue Fever",
  "icd10_codes": ["A90", "A91"],
  "red_flags": [
    {
      "symptom": "Severe abdominal pain or persistent vomiting",
      "severity": "critical",
      "action": "Immediate IV fluids, monitor for dengue hemorrhagic fever",
      "timeframe": "immediate"
    },
    {
      "symptom": "Bleeding (epistaxis, gum bleeding, blood in vomit/stool)",
      "severity": "critical",
      "action": "Admit to hospital, monitor platelet count and hematocrit",
      "timeframe": "within 1 hour"
    },
    {
      "symptom": "Signs of plasma leakage (pleural effusion, ascites)",
      "severity": "critical",
      "action": "IV crystalloid resuscitation, intensive monitoring",
      "timeframe": "immediate"
    },
    {
      "symptom": "Altered consciousness or lethargy",
      "severity": "critical",
      "action": "Check for dengue shock syndrome, aggressive fluid resuscitation",
      "timeframe": "immediate"
    },
    {
      "symptom": "Platelet count < 50,000 with bleeding",
      "severity": "high",
      "action": "Hospital admission, platelet transfusion if active bleeding",
      "timeframe": "within 1 hour"
    }
  ],
  "diagnostic_criteria": [
    {
      "category": "clinical",
      "criteria": [
        "Sudden onset high fever (39-40Â°C)",
        "Severe headache (especially retro-orbital pain)",
        "Myalgia and arthralgia (break-bone fever)",
        "Rash (maculopapular, appears day 3-5)",
        "Travel to or residence in dengue-endemic area"
      ],
      "minimum_required": 3,
      "specificity": 0.5,
      "sensitivity": 0.8
    },
    {
      "category": "laboratory",
      "criteria": [
        "Positive dengue NS1 antigen (early: days 1-5)",
        "Positive dengue IgM antibody (day 4 onwards)",
        "Positive dengue IgG antibody (secondary infection)",
        "Positive dengue PCR"
      ],
      "minimum_required": 1,
      "specificity": 0.95,
      "sensitivity": 0.85
    },
    {
      "category": "laboratory",
      "criteria": [
        "Thrombocytopenia (platelet count < 100,000)",
        "Hemoconcentration (hematocrit increased by 20%)",
        "Leukopenia (WBC < 5,000)"
      ],
      "minimum_required": 1,
      "specificity": 0.6,
      "sensitivity": 0.7
    }
  ],
  "treatment_algorithm": [
    {
      "step_number": 1,
      "title": "Classify Dengue Severity",
      "description": "Use WHO 2009 classification to guide management",
      "medications": [],
      "duration": "Initial assessment",
      "follow_up": "Re-assess daily during critical phase (days 3-7)",
      "special_considerations": [
        "Group A (Dengue without warning signs): Can be managed at home",
        "Group B (Dengue with warning signs): Requires hospital observation",
        "Group C (Severe dengue): Requires ICU admission and aggressive management",
        "Warning signs: abdominal pain, persistent vomiting, mucosal bleeding, lethargy, liver enlargement, rising hematocrit with falling platelets"
      ]
    },
    {
      "step_number": 2,
      "title": "Group A: Outpatient Management",
      "description": "Home care for uncomplicated dengue",
      "medications": [
        {
          "name": "Paracetamol",
          "generic_name": "acetaminophen",
          "dosage": "500-1000 mg for adults, 15 mg/kg for children",
          "route": "oral",
          "frequency": "Every 6 hours as needed",
          "duration": "Until fever subsides",
          "contraindications": ["Severe liver disease"],
          "side_effects": ["Rare: hepatotoxicity at high doses"],
          "cost_usd": 0.05
        }
      ],
      "duration": "5-7 days",
      "follow_up": "Daily clinic visit or phone check during critical phase (days 3-7)",
      "special_considerations": [
        "AVOID: Aspirin, NSAIDs, IM injections (bleeding risk)",
        "Encourage oral fluids: 2-3 liters/day",
        "Bed rest during febrile phase",
        "Return immediately if warning signs develop",
        "Monitor platelet count every 1-2 days"
      ]
    },
    {
      "step_number": 3,
      "title": "Group B: Hospital Observation",
      "description": "For dengue with warning signs",
      "medications": [
        {
          "name": "IV Crystalloid Fluids",
          "generic_name": "normal saline or Ringer's lactate",
          "dosage": "5-7 mL/kg/hour initially",
          "route": "IV",
          "frequency": "Continuous infusion",
          "duration": "24-48 hours or until stable",
          "contraindications": [],
          "side_effects": ["Fluid overload if excessive"],
          "cost_usd": 2.0
        }
      ],
      "duration": "2-3 days minimum",
      "follow_up": "Monitor vitals every 1-2 hours, hematocrit every 6-12 hours",
      "special_considerations": [
        "Titrate IV fluids based on clinical response",
        "If hematocrit stable and improving: reduce fluids to 3-5 mL/kg/h",
        "If hematocrit rising: increase fluids to 5-10 mL/kg/h",
        "Watch for fluid overload: stop IV when hematocrit normalizing and adequate oral intake"
      ]
    },
    {
      "step_number": 4,
      "title": "Group C: Severe Dengue (ICU)",
      "description": "For dengue shock syndrome or severe organ impairment",
      "medications": [
        {
          "name": "IV Crystalloid Bolus",
          "generic_name": "normal saline or Ringer's lactate",
          "dosage": "10-20 mL/kg over 15-30 minutes",
          "route": "IV",
          "frequency": "Repeat up to 3 times if needed",
          "duration": "Until shock reverses",
          "contraindications": [],
          "side_effects": ["Pulmonary edema if excessive"],
          "cost_usd": 5.0
        },
        {
          "name": "Platelet Transfusion",
          "generic_name": "platelet concentrate",
          "dosage": "1 unit per 10 kg body weight",
          "route": "IV",
          "frequency": "As needed",
          "duration": "Only if platelets < 10,000 with bleeding",
          "contraindications": [],
          "side_effects": ["Transfusion reactions"],
          "cost_usd": 50.0
        }
      ],
      "duration": "3-7 days ICU stay",
      "follow_up": "Hourly vital signs, hematocrit every 4-6 hours",
      "special_considerations": [
        "If shock persists after 3rd bolus: consider colloid (albumin or plasma)",
        "Do NOT give platelets prophylactically (only if < 10,000 with bleeding)",
        "Monitor for complications: pulmonary edema, ARDS, acute liver failure",
        "Avoid over-resuscitation: causes pulmonary edema"
      ]
    }
  ],
  "differential_diagnosis": [
    {
      "condition": "Malaria",
      "icd10_code": "B54",
      "distinguishing_features": [
        "Positive malaria RDT or smear",
        "Less severe myalgia/arthralgia",
        "Responds to antimalarials",
        "No rash typically"
      ],
      "prevalence": "common"
    },
    {
      "condition": "Chikungunya",
      "icd10_code": "A92.0",
      "distinguishing_features": [
        "Severe arthralgia (worse than dengue)",
        "Joint pain can persist for months",
        "Less severe thrombocytopenia",
        "IgM positive for chikungunya"
      ],
      "prevalence": "common"
    },
    {
      "condition": "Influenza",
      "icd10_code": "J11.1",
      "distinguishing_features": [
        "Respiratory symptoms prominent",
        "Seasonal pattern",
        "No significant thrombocytopenia",
        "Positive influenza test"
      ],
      "prevalence": "common"
    },
    {
      "condition": "Leptospirosis",
      "icd10_code": "A27.9",
      "distinguishing_features": [
        "Conjunctival suffusion",
        "Exposure to contaminated water",
        "Kidney and liver involvement",
        "Positive leptospira serology"
      ],
      "prevalence": "uncommon"
    }
  ],
  "complications": [
    {
      "name": "Dengue hemorrhagic fever",
      "icd10_code": "A91",
      "risk_factors": ["Secondary dengue infection", "Age < 15 years", "Female gender"],
      "prevention": "Early recognition and fluid management",
      "management": "Aggressive IV fluid resuscitation, platelet transfusion if severe bleeding"
    },
    {
      "name": "Dengue shock syndrome",
      "icd10_code": "A91",
      "risk_factors": ["Severe plasma leakage", "Delayed presentation", "Comorbidities"],
      "prevention": "Timely IV fluid therapy when warning signs appear",
      "management": "Crystalloid bolus 10-20 mL/kg, repeat up to 3 times, then colloid if needed"
    },
    {
      "name": "Acute liver failure",
      "risk_factors": ["Severe dengue", "Pre-existing liver disease"],
      "prevention": "Avoid hepatotoxic drugs (aspirin, NSAIDs)",
      "management": "Supportive care, may require liver transplant if fulminant"
    },
    {
      "name": "Encephalopathy",
      "risk_factors": ["Severe dengue", "Liver failure", "Electrolyte imbalance"],
      "prevention": "Maintain adequate perfusion, correct metabolic abnormalities",
      "management": "Supportive ICU care, treat underlying cause"
    }
  ],
  "prevention": [
    {
      "type": "primary",
      "intervention": "Vector control (eliminate mosquito breeding sites)",
      "target_population": "All residents in dengue-endemic areas",
      "effectiveness": "Removing stagnant water reduces Aedes mosquito population by 70-90%"
    },
    {
      "type": "primary",
      "intervention": "Personal protection (repellents, long sleeves, bed nets)",
      "target_population": "Individuals in endemic areas during outbreaks",
      "effectiveness": "DEET-based repellents reduce bites by 80-90%"
    },
    {
      "type": "primary",
      "intervention": "Dengue vaccine (Dengvaxia, TAK-003)",
      "target_population": "Individuals 9-45 years with previous dengue infection",
      "effectiveness": "Reduces severe dengue by 80%, only for seropositive individuals"
    },
    {
      "type": "secondary",
      "intervention": "Early case detection and management",
      "target_population": "All suspected dengue cases",
      "effectiveness": "Reduces mortality from 20% to < 1% with proper fluid management"
    }
  ],
  "references": [
    {
      "title": "WHO Dengue Guidelines for diagnosis, treatment, prevention and control",
      "source": "WHO",
      "url": "https://www.who.int/publications/i/item/9789241547871",
      "year": 2009,
      "evidence_level": "A"
    },
    {
      "title": "Comprehensive guideline for prevention and control of dengue and dengue haemorrhagic fever",
      "source": "WHO SEARO",
      "url": "https://apps.who.int/iris/handle/10665/204894",
      "year": 2011,
      "evidence_level": "A"
    },
    {
      "title": "CDC Dengue Clinical Guidance",
      "source": "CDC",
      "url": "https://www.cdc.gov/dengue/healthcare-providers/clinical-presentation.html",
      "year": 2023,
      "evidence_level": "A"
    }
  ]
}
